Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pamela S Ohashi

Showing results (1-10 of 204) with videos related to

Pageof 21
Sort By:
Nature Reviews. Immunology|July 3, 2002
T-cell signalling and autoimmunity: molecular mechanisms of diseasePamela S Ohashi
Current Opinion in Immunology|November 25, 2003
Negative selection and autoimmunityPamela S Ohashi
Cancer Immunology Research|September 4, 2016
Zeroing in on Tumor-Reactive TILsPamela S Ohashi
Science (New York, N.Y.)|November 16, 2002
Immunology. Exposing thy selfPamela S Ohashi
Cell Research|May 6, 2020
ILC transdifferentiation: roles in cancer progressionMaryam Ghaedi, Pamela S Ohashi
Current Opinion in Immunology|May 14, 2021
Editorial overview: Cancer Immunotherapy: Are we there yet?Pamela S Ohashi, Arlene Sharpe
Seminars in Immunology|August 7, 2019
ILC regulation of T cell responses in inflammatory diseases and cancerKathrin Warner, Pamela S Ohashi
Oncoimmunology|March 5, 2016
B7-H4 is a positive regulator of antitumor immunityRamtin Rahbar, Pamela S Ohashi
Current Opinion in Immunology|November 25, 2003
AutoimmunityNora Sarvetnick, Pamela S Ohashi
Advances in Cancer Research|July 28, 2019
Expression of costimulatory and inhibitory receptors in FoxP3<sup>+</sup> regulatory T cells within the tumor microenvironment: Implications for combination immunotherapy approachesAras Toker, Pamela S Ohashi
Pageof 21

Showing results (1-10 of 204) with videos related to

Sort By:
Pageof 21
Nature Reviews. Immunology|July 3, 2002
T-cell signalling and autoimmunity: molecular mechanisms of diseasePamela S Ohashi
Current Opinion in Immunology|November 25, 2003
Negative selection and autoimmunityPamela S Ohashi
Cancer Immunology Research|September 4, 2016
Zeroing in on Tumor-Reactive TILsPamela S Ohashi
Science (New York, N.Y.)|November 16, 2002
Immunology. Exposing thy selfPamela S Ohashi
Cell Research|May 6, 2020
ILC transdifferentiation: roles in cancer progressionMaryam Ghaedi, Pamela S Ohashi
Current Opinion in Immunology|May 14, 2021
Editorial overview: Cancer Immunotherapy: Are we there yet?Pamela S Ohashi, Arlene Sharpe
Seminars in Immunology|August 7, 2019
ILC regulation of T cell responses in inflammatory diseases and cancerKathrin Warner, Pamela S Ohashi
Oncoimmunology|March 5, 2016
B7-H4 is a positive regulator of antitumor immunityRamtin Rahbar, Pamela S Ohashi
Current Opinion in Immunology|November 25, 2003
AutoimmunityNora Sarvetnick, Pamela S Ohashi
Advances in Cancer Research|July 28, 2019
Expression of costimulatory and inhibitory receptors in FoxP3<sup>+</sup> regulatory T cells within the tumor microenvironment: Implications for combination immunotherapy approachesAras Toker, Pamela S Ohashi
Pageof 21